Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways

Laboratory Investigation

Volumn 77, Issue 3, 1997, Pages 257-267

  Slowik, Mark R ^a,b   Min, Wang ^a   Ardito, Thomas ^a,b   Karsan, Aly ^c   Kashgarian, Michael ^b   Pober, Jordan S ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE DERIVATIVE; CYCLOHEXIMIDE; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; PROTEIN; PROTEIN BCL 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

APOPTOSIS; CASPASE 1; CELLS, CULTURED; CERAMIDES; CYCLOHEXIMIDE; CYSTEINE ENDOPEPTIDASES; DRUG RESISTANCE; ENDOPEPTIDASES; ENDOTHELIUM, VASCULAR; HUMANS; MICROSCOPY, ELECTRON; PROTEIN SYNTHESIS INHIBITORS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030775519     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, and Kronke M (1996). FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86:937-947.
2. Beg AA and Baltimore D (1996). An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-784.
3. Beutler B (1992). Tumor necrosis factors: The molecules and their emerging role in medicine. New York: Raven Press.
4. Chinnaiyan AM, O'Rourke K, Lane BR, and Dixit VM (1997). Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 275:1122-1126.
5. Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, and Ferran C (1996). A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem 271: 18068-18073.
6. Dbaibo GS, Perry DK, Gamard CJ, Platt R, Poirier GG, Obeid LM, and Hannun YA (1997). Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J Exp Med 185:481-490.
7. De Luca LG, Johnson DR, Whitely MZ, Collins T, and Pober JS (1994). cAMP and tumor necrosis factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter. J Biol Chem 269: 19193-19196.
8. Dimmeler S, Haendeler J, Nehls M, and Zeiher AM (1997). Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. 185:601-607.
9. Dimmeler S, Haendeler J, Rippmann V, Nehls M, and Zeiher AM (1996). Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett 399:71-74.
10. Eissner G, Kohlhuber F, Grell M, Ueffing M, Scheurich P, Hieke A, Multhoff G, Bornkamm GW, and Holler E (1995). Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 86: 4184-4193.
11. Haendeler J, Zeiher AM, and Dimmeler S (1996). Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur J Pharmacol 317:407-411.
12. Hannun Y (1996). Functions of ceramide in coordinating cellular responses to stress. Science 274:1855-1859.
13. Henkart PA (1996). ICE family proteases: Mediators of all apoptotic cell death? Immunity 4:195-201.
14. Hsu H, Shu H-B, Pan M-G, and Goeddel DV (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299-308.
15. Joseph CK, Wright SD, Bornmann WG, Randolph JT, Kumar ER, Bittman R, Liu J, and Kolesnick RN (1994). Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J Biol Chem 269:17606-17610.
16. Kaiser D, Freyberg MA, and Freidl P (1997). Lack of hemodynamic forces triggers apoptosis in vascular endothelial cells. Biochem Biophys Res Commun 231:586-590.
17. Karmann K, Wang Min, Fanslow WC, and Pober JS (1996). Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. J Exp Med 184:173-182.
18. Karnovsky MJ (1965). A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy (abstract). J Cell Biol 27:137.
19. Karsan A, Yee E, Kaushansky K, and Harlan JM (1996a). Cloning of a human Bcl-2 homologue: Inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 87:3089-3096.
20. Karsan A, Yee E, and Harlan JM (1996b). Endothelial cell death induced by tumor necrosis factor-α is inhibited by the Bcl-2 family member, A1. J Biol Chem 271:27201-27204.
21. Kluck RM, Bossy-Wetzel E, Green DR, and Newmeyer DD (1997). The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136.
22. Liu ZG, Hsu H, Goeddel DV, and Karin M (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565-576.
23. Loetscher H, Stueber D, Banner D, Mackay F, and Lesslauer W (1993). Human tumor necrosis factor α (TNFα) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J Biol Chem 268:26350-26357.
24. Mackay F, Loetscher H, Stueber D, Gehr G, and Lesslauer W (1993). Tumor necrosis factor-α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 177:1277-1286.
25. Opipari AW, Boguski MS, and Dixit VM (1990). The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem 265:14705-14708.
26. Opipari AW, Hu HM, Yabkowitz R, and Dixit VM (1992). The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 267:12424-12427.
27. Pober JS and Cotran RS (1990). Cytokines and endothelial cell biology. Physiol Rev 70:427-451.
28. Pober JS, Slowik MR, DeLuca LG, and Ritchie AJ (1993). Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 150:5114-5123.
29. Pohlman TH and Harlan JM (1989). Human endothelial cell response to lipopolycaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell Immunol 119:41-52.
30. Rothstein JL and Schreiber H (1988). Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and shock in normal mice. Proc Natl Acad Sci USA 85:607-611.
31. Slowik MR, DeLuca LG, Fiers W, and Pober JS (1993). Tumor necrosis factor (TNF) activates human endothelial cells through the p55 TNF receptor but the p75 receptor contributes to activation at low TNF concentration. Am J Pathol 143:1724-1730.
32. Slowik MR, De Luca LG, Wang Min, and Pober JS (1996). Ceramide is not a signal for tumor necrosis factor-induced gene expression but does cause programmed cell death in human vascular endothelial cells. Circ Res 79:736-747.
33. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, and Kroemer G (1996). Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184:1331-1341.
34. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, and Verma IM (1996). Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789.
35. Van Ostade X, Vandenabeele P, Everaerdt B, Loetscher H, Brouckaert P, and Fiers W (1993). Human TNF mutants with selective activity on the p55 receptor. Nature 361:266-269.
36. Vaux DL and Strasser A (1996). The molecular biology of apoptosis. Proc Natl Acad Sci USA 93:2239-2244.
37. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, and Kolesnick RN (1996). Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature 380:75-79.
38. Wang C-U, Mayo M, and Baldwin Jr AS (1996a). TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274:784-787.
39. Wang JH, Redmond HP, Watson RW, Condron C, and Bouchier-Hayes D (1996b). The beneficial effect of taurine on the prevention of human endothelial cell death. Shock. 6:331-338.
40. Wiegmann K, Schutze S, Machiedt T, Witte D, and Kronke M (1994). Functional dichotomy of neutral and acidic sphingo-myelinases in tumor necrosis factor signaling. Cell 78:1005-1015.
41. Wu D, Wallen HD, and Nunez G (1997). Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 275:1126-1129.
42. Yang J, Liu X, Bhalla K, Naekyung Kim C, Ibrado AM, Cai J, Peng T-I, Jones DP, and Wang X (1997). Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275:1129-1132.
43. Zhang J, Alter N, Reed JC, Borner C, Obeid LM, and Hannun YA (1996). Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc Natl Acad Sci USA 93:5325-5328.